J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergthorsson, J T
Right arrow Articles by Niebuhr, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergthorsson, J T
Right arrow Articles by Niebuhr, E
J Med Genet 2001;38:361-368 ( June )

BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age

J T Bergthorssona b, B Ejlertsenc, J H Olsend, A Borge, K V Nielsena, R B Barkardottirb, S Klausenf, H T Mouridsenc, K Winthera, K Fengera, A Niebuhra, T L Harboea, E Niebuhra

a Department of Medical Genetics, Institute for Medical Biochemistry and Genetics, Panum Institute, Blegdamsvej 3, 2200 Copenhagen N, Denmark, b Laboratory of Cell Biology, Department of Pathology, University Hospital of Iceland, Landspitalinn, Building 14, 101 Reykjavik, Iceland, c Department of Oncology, The Finsen Centre, Rigshospitalet, Building 5-01-2, Blegdamsvej 9, 2100 Copenhagen, Denmark, d Division for Cancer Epidemiology, Danish Cancer Society, Strandboulevarden 49, 2100 Copenhagen, Denmark, e Department of Oncology, University Hospital, S-221 85 Lund, Sweden, f Department of Anatomy and Pathology, Herlev University Hospital, Herlev Ringvej, 2730 Herlev, Denmark

Correspondence to: Dr Bergthorsson, Iceland, nonni{at}rsp.is

Revised version received 26 March 2001; Accepted for publication 27 March 2001

INTRODUCTION---A small fraction of breast cancer is the result of germline mutations in the BRCA1 and BRCA2 cancer susceptibility genes. Mutation carriers frequently have a positive family history of breast and ovarian cancer, are often diagnosed at a young age, and may have a higher incidence of double or multiple primary breast tumours than breast cancer patients in general.
OBJECTIVES---To estimate the prevalence and spectrum of BRCA1 and BRCA2 mutations in young Danish patients affected with bilateral or multifocal breast cancer and to determine the relationship of mutation status to family history of cancer.
SUBJECTS---From the files of the Danish Breast Cancer Cooperative Group (DBCG), we selected 119 breast cancer patients diagnosed before the age of 46 years with either bilateral (n=59) or multifocal (n=61) disease.
METHODS---DNA from the subjects was screened for BRCA1 and BRCA2 mutations using single strand conformation analysis (SSCA) and the protein truncation test (PTT). Observed and expected cancer incidence in first degree relatives of the patients was estimated using data from the Danish Cancer Registry.
RESULTS---Twenty four mutation carriers were identified (20%), of whom 13 had a BRCA1 mutation and 11 carried a BRCA2 mutation. Two mutations in BRCA1 were found repeatedly in the material and accounted for seven of the 24 (29%) mutation carriers. The mutation frequency was about equal in patients with bilateral (22%) and multifocal breast cancer (18%). The incidence of breast and ovarian cancer was greatly increased in first degree relatives of BRCA1 and BRCA2 mutation carriers, but to a much lesser degree in relatives of non-carriers. An increased risk of cancer was also noted in brothers of non-carriers.
CONCLUSIONS---A relatively broad spectrum of germline mutations was observed in BRCA1 and BRCA2 and most of the mutations are present in other populations. Our results indicate that a diagnosis of bilateral and multifocal breast cancer is predictive of BRCA1 and BRCA2 mutation status, particularly when combined with information on the patients' age at diagnosis and family history of breast/ovarian cancer.


Keywords: breast cancer; mutations; BRCA1; BRCA2


© 2001 by J Med Genet



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. Soegaard, S. K. Kjaer, M. Cox, E. Wozniak, E. Hogdall, C. Hogdall, J. Blaakaer, I. J. Jacobs, S. A. Gayther, and S. J. Ramus
BRCA1 and BRCA2 Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark
Clin. Cancer Res., June 15, 2008; 14(12): 3761 - 3767.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Ang, I. H.K. Lim, T.-C. Lee, J.-T. Luo, D. C.T. Ong, P. H. Tan, and A. S.G. Lee
BRCA1 and BRCA2 Mutations in an Asian Clinic-based Population Detected Using a Comprehensive Strategy
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2276 - 2284.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. M. Suter, R. M. Ray, Y. W. Hu, M. G. Lin, P. Porter, D. L. Gao, R. E. Zaucha, L. M. Iwasaki, L. P. Sabacan, M. C. Langlois, et al.
BRCA1 and BRCA2 Mutations in Women from Shanghai China
Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 181 - 189.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd.